Evidence map›Paper›PMID 38845630›Full record

ArticleProceedings of the European Academy of Sciences & Arts2024

FAIR reporting of clinical trials for public health practice.

E Andrew Balas, Bussi S Bussi, Noha Asem, Caroline Amour, Charles Mwanziva, Jose Vazquez, Nargis A Labib, Matthew Price, Michael J Mahande, Rohitha Baskar and 3 more

Abstract read
In one paragraph

Article in Proceedings of the European Academy of Sciences & Arts, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

E Andrew BalasBiomedical Research Innovation Laboratory, Augusta University, Augusta, GA, USA.
Bussi S BussiMilitary College of Medical Sciences, Kawe, Dar es Salaam, Tanzania.
Noha AsemDepartment of Public Health, Cairo University, Egypt.
Caroline AmourInstitute of Public Health, Kilimanjaro Christian Medical University College, Tanzania.
Charles MwanzivaMilitary College of Medical Sciences, Kawe, Dar es Salaam, Tanzania.
Jose VazquezMedical College of Georgia, Augusta University, Augusta, GA, USA.
Nargis A LabibDepartment of Public Health, Cairo University, Egypt.
Matthew PriceBiomedical Research Innovation Laboratory, Augusta University, Augusta, GA, USA.
Michael J MahandeInstitute of Public Health, Kilimanjaro Christian Medical University College, Tanzania.
Rohitha BaskarNew York Presbyterian Brooklyn Methodist Hospital, New York, NY, USA.
Saidharshana DhantuUniversity of Alabama at Birmingham, Birmingham, AL, USA.
Tiffany G TownsendPurdue University Global, West Lafayette, IN, USA.
Clément AubertSchool of Computer and Cyber Sciences, Augusta University, Augusta, GA, USA.

Funding

SCISIPBIO: Distinguishing practices of outstanding productivity and expansion in biomedical researchR01GM146338 · NIGMS · AUGUSTA UNIVERSITY · PI BALAS, E ANDREW · 2021 to 2023
$609k
NIGMS NIH HHS R01 GM146338
6 · The paper itself

Abstract

The number of clinical trials is rapidly growing, and automation of literature processing is becoming desirable but unresolved. Our purpose was to assess and increase the readiness of clinical trial reports for supporting automated retrieval and implementation in public health practice. We searched the Medline database for a random sample of clinical trials of HIV/AIDS management with likely relevance to public health in Africa. Five authors assessed trial reports for inclusion, extracted data, and assessed quality based on the FAIR principles of scientific data management (findable, accessible, interoperable, and reusable). Subsequently, we categorized reported results in terms of outcomes and essentials of implementation. A sample of 96 trial reports was selected. Information about the tested intervention that is essential for practical implementation was largely missing, including personnel resources needed 32·3% (.95 CI: 22·9-41·6); material/supplies needed 33·3% (.95 CI: 23·9-42·8); major equipment/building investment 42·8% (CI: 33·8-53·7); methods of educating providers 53·1% (CI: 43·1-63·4); and methods of educating the community 27·1% (CI: 18·2-36·0). Overall, 65% of studies measured health/biologic outcomes, among them, only a fraction showed any positive effects. Several specific design elements were identified that frequently make clinical trials unreal and their results unusable. To sort and interpret clinical trial results easier and faster, a new reporting structure, a practice- and retrieval-oriented trial outline with numeric outcomes (PROTON) table was developed and illustrated. Many clinical trials are either inconsequential by design or report incomprehensible results. According to the latest expectations of FAIR scientific data management, all clinical trial reports should include a consistent and practical impact-oriented table of clinical trial results.

Indexed as

clinical trialspublic health practice

Identifiers

PMID38845630
PMCPMC11154655

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.